Feb 26 (Reuters) - Canada's drug regulator approved AstraZeneca (NASDAQ:AZN)'s AZN.L COVID-19 vaccine on Friday, the third inoculation to get a green light.
The vaccine was approved under Canada's interim order system, which allows for accelerated approvals similar to the U.S. Food and Drug Administration's emergency use authorizations.